ARTICLE | Clinical News
MM-121: Phase II started
March 23, 2015 7:00 AM UTC
Merrimack began an open-label, international Phase II trial to compare MM-121 plus docetaxel or pemetrexed vs. docetaxel or pemetrexed alone in about 120 patients who have progressed following <=2 pri...